Skip to main content
Top
Published in: Pediatric Rheumatology 1/2020

Open Access 01-12-2020 | Vasculitis | Case Report

Heme oxygenase-1 deficiency presenting with interstitial lung disease and hemophagocytic flares

Authors: Alice S. Chau, Bonnie L. Cole, Jason S. Debley, Kabita Nanda, Aaron B. I. Rosen, Michael J. Bamshad, Deborah A. Nickerson, Troy R. Torgerson, Eric J. Allenspach

Published in: Pediatric Rheumatology | Issue 1/2020

Login to get access

Abstract

Background

Heme oxygenase-1 (HMOX1) catalyzes the metabolism of heme into carbon monoxide, ferrous iron, and biliverdin. Through biliverdin reductase, biliverdin becomes bilirubin. HMOX1-deficiency is a rare autosomal recessive disorder with hallmark features of direct antibody negative hemolytic anemia with normal bilirubin, hyperinflammation and features similar to macrophage activation syndrome. Clinical findings have included asplenia, nephritis, hepatitis, and vasculitis. Pulmonary features and evaluation of the immune response have been limited.

Case presentation

We present a young boy who presented with chronic respiratory failure due to nonspecific interstitial pneumonia following a chronic history of infection-triggered recurrent hyperinflammatory flares. Episodes included hemolysis without hyperbilirubinemia, immunodeficiency, hepatomegaly with mild transaminitis, asplenia, leukocytosis, thrombocytosis, joint pain and features of macrophage activation with negative autoimmune serologies. Lung biopsy revealed cholesterol granulomas. He was found post-mortem by whole exome sequencing to have a compound heterozygous paternal frame shift a paternal frame shift HMOX1(NM_002133.3):c.262_268delGCCCTGGinsCC (p.Ala88Profs*51) and maternal splice donor HMOX1 (c.636 + 2 T > A) consistent with HMOX1 deficiency. Western blot analysis confirmed lack of HMOX1 protein upon oxidant stimulation of the patient cells.

Conclusions

Here, we describe a phenotype expansion for HMOX1-deficiency to include not only asplenia and hepatomegaly, but also interstitial lung disease with cholesterol granulomas and inflammatory flares with hemophagocytosis present in the bone marrow.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A. 1968;61(2):748–55.CrossRef Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A. 1968;61(2):748–55.CrossRef
2.
go back to reference Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999;103(1):129–35.CrossRef Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999;103(1):129–35.CrossRef
3.
go back to reference Kawashima A, Oda Y, Yachie A, Koizumi S, Nakanishi I. Heme oxygenase-1 deficiency: the first autopsy case. Hum Pathol. 2002;33(1):125–30.CrossRef Kawashima A, Oda Y, Yachie A, Koizumi S, Nakanishi I. Heme oxygenase-1 deficiency: the first autopsy case. Hum Pathol. 2002;33(1):125–30.CrossRef
4.
go back to reference Radhakrishnan N, Yadav SP, Sachdeva A, Pruthi PK, Sawhney S, Piplani T, et al. Human heme oxygenase-1 deficiency presenting with hemolysis, nephritis, and asplenia. J Pediatr Hematol Oncol. 2011;33(1):74–8.CrossRef Radhakrishnan N, Yadav SP, Sachdeva A, Pruthi PK, Sawhney S, Piplani T, et al. Human heme oxygenase-1 deficiency presenting with hemolysis, nephritis, and asplenia. J Pediatr Hematol Oncol. 2011;33(1):74–8.CrossRef
5.
go back to reference Radhakrishnan N, Yadav SP, Sachdeva A, Wada T, Yachie A. An interesting tetrad of asplenia, inflammation, hemolysis, and nephritis. Pediatr Hematol Oncol. 2011;28:723–6.CrossRef Radhakrishnan N, Yadav SP, Sachdeva A, Wada T, Yachie A. An interesting tetrad of asplenia, inflammation, hemolysis, and nephritis. Pediatr Hematol Oncol. 2011;28:723–6.CrossRef
6.
go back to reference Gupta A, Akihiro Y, Saxena AK, Bhattacharya A, Singh S. Haem oxygenase-1 deficiency: a mimicker of childhood vasculitis. Scand J Rheumatol. 2016;45(2):165–6.CrossRef Gupta A, Akihiro Y, Saxena AK, Bhattacharya A, Singh S. Haem oxygenase-1 deficiency: a mimicker of childhood vasculitis. Scand J Rheumatol. 2016;45(2):165–6.CrossRef
7.
go back to reference Greil J, Verga-Falzacappa MV, Echner NE, Behnisch W, Bandapalli OR, Pechanska P, et al. Mutating heme oxygenase-1 into a peroxidase causes a defect in bilirubin synthesis associated with microcytic anemia and severe hyperinflammation. Haematologica. 2016;101(11):e436–e9.CrossRef Greil J, Verga-Falzacappa MV, Echner NE, Behnisch W, Bandapalli OR, Pechanska P, et al. Mutating heme oxygenase-1 into a peroxidase causes a defect in bilirubin synthesis associated with microcytic anemia and severe hyperinflammation. Haematologica. 2016;101(11):e436–e9.CrossRef
8.
go back to reference Tahghighi F, Parvaneh N, Ziaee V. Post-mortem diagnosis of Heme Oxygenase-1 deficiency by whole exome sequencing in an Iranian child. Int J Mol Cell Med. 2019;8(4):300–6.PubMedPubMedCentral Tahghighi F, Parvaneh N, Ziaee V. Post-mortem diagnosis of Heme Oxygenase-1 deficiency by whole exome sequencing in an Iranian child. Int J Mol Cell Med. 2019;8(4):300–6.PubMedPubMedCentral
9.
go back to reference Ozen M, Zhao H, Lewis DB, Wong RJ, Stevenson DK. Heme oxygenase and the immune system in normal and pathological pregnancies. Front Pharmacol. 2015;6:84.CrossRef Ozen M, Zhao H, Lewis DB, Wong RJ, Stevenson DK. Heme oxygenase and the immune system in normal and pathological pregnancies. Front Pharmacol. 2015;6:84.CrossRef
10.
go back to reference Tsur A, Kalish F, Burgess J, Nayak NR, Zhao H, Casey KM, et al. Pravastatin improves fetal survival in mice with a partial deficiency of heme oxygenase-1. Placenta. 2019;75:1–8.CrossRef Tsur A, Kalish F, Burgess J, Nayak NR, Zhao H, Casey KM, et al. Pravastatin improves fetal survival in mice with a partial deficiency of heme oxygenase-1. Placenta. 2019;75:1–8.CrossRef
11.
go back to reference Fan LL, Dishop MK, Galambos C, Askin FB, White FV, Langston C, et al. Diffuse lung disease in biopsied children 2 to 18 years of age. Application of the chILD classification scheme. Ann Am Thorac Soc. 2015;12(10):1498–505.CrossRef Fan LL, Dishop MK, Galambos C, Askin FB, White FV, Langston C, et al. Diffuse lung disease in biopsied children 2 to 18 years of age. Application of the chILD classification scheme. Ann Am Thorac Soc. 2015;12(10):1498–505.CrossRef
12.
go back to reference Cottin V, Hirani NA, Hotchkin DL, Nambiar AM, Ogura T, Otaola M, et al. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 2018;27(150):180076.CrossRef Cottin V, Hirani NA, Hotchkin DL, Nambiar AM, Ogura T, Otaola M, et al. Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev. 2018;27(150):180076.CrossRef
13.
go back to reference Nathan N, Borensztajn K, Clement A. Genetic causes and clinical management of pediatric interstitial lung diseases. Curr Opin Pulm Med. 2018;24(3):253–9.CrossRef Nathan N, Borensztajn K, Clement A. Genetic causes and clinical management of pediatric interstitial lung diseases. Curr Opin Pulm Med. 2018;24(3):253–9.CrossRef
14.
go back to reference Fisher M, Roggli V, Merten D, Mulvihill D, Spock A. Coexisting endogenous lipoid pneumonia, cholesterol granulomas, and pulmonary alveolar proteinosis in a pediatric population: a clinical, radiographic, and pathologic correlation. Pediatr Pathol. 1992;12(3):365–83.CrossRef Fisher M, Roggli V, Merten D, Mulvihill D, Spock A. Coexisting endogenous lipoid pneumonia, cholesterol granulomas, and pulmonary alveolar proteinosis in a pediatric population: a clinical, radiographic, and pathologic correlation. Pediatr Pathol. 1992;12(3):365–83.CrossRef
15.
go back to reference Marangu D, Gray D, Vanker A, Zampoli M. Exogenous lipoid pneumonia in children: a systematic review. Paediatr Respir Rev. 2020;33:45–51. Marangu D, Gray D, Vanker A, Zampoli M. Exogenous lipoid pneumonia in children: a systematic review. Paediatr Respir Rev. 2020;33:45–51.
16.
go back to reference Hu X, Lee JS, Pianosi PT, Ryu JH. Aspiration-related pulmonary syndromes. Chest. 2015;147(3):815–23.CrossRef Hu X, Lee JS, Pianosi PT, Ryu JH. Aspiration-related pulmonary syndromes. Chest. 2015;147(3):815–23.CrossRef
17.
go back to reference Glancy DL, Frazier PD, Roberts WC. Pulmonary parenchymal cholesterol-ester granulomas in patients with pulmonary hypertension. Am J Med. 1968;45(2):198–210.CrossRef Glancy DL, Frazier PD, Roberts WC. Pulmonary parenchymal cholesterol-ester granulomas in patients with pulmonary hypertension. Am J Med. 1968;45(2):198–210.CrossRef
18.
go back to reference Fischer EG, Marek JM, Morris A, Nashelsky MB. Cholesterol granulomas of the lungs associated with microangiopathic hemolytic anemia and thrombocytopenia in pulmonary hypertension. Arch Pathol Lab Med. 2000;124(12):1813–5.CrossRef Fischer EG, Marek JM, Morris A, Nashelsky MB. Cholesterol granulomas of the lungs associated with microangiopathic hemolytic anemia and thrombocytopenia in pulmonary hypertension. Arch Pathol Lab Med. 2000;124(12):1813–5.CrossRef
19.
go back to reference Schultz R, Mattila J, Gappa M, Verronen P. Development of progressive pulmonary interstitial and intra-alveolar cholesterol granulomas (PICG) associated with therapy-resistant chronic systemic juvenile arthritis (CJA). Pediatr Pulmonol. 2001;32(5):397–402.CrossRef Schultz R, Mattila J, Gappa M, Verronen P. Development of progressive pulmonary interstitial and intra-alveolar cholesterol granulomas (PICG) associated with therapy-resistant chronic systemic juvenile arthritis (CJA). Pediatr Pulmonol. 2001;32(5):397–402.CrossRef
20.
go back to reference Choi AM, Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol. 1996;15(1):9–19.CrossRef Choi AM, Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol. 1996;15(1):9–19.CrossRef
21.
go back to reference Saper VE, Chen G, Deutsch GH, Guillerman RP, Birgmeier J, Jagadeesh K, et al. Emergent high fatality lung disease in systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2019;78:1722–31.CrossRef Saper VE, Chen G, Deutsch GH, Guillerman RP, Birgmeier J, Jagadeesh K, et al. Emergent high fatality lung disease in systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2019;78:1722–31.CrossRef
22.
go back to reference Minoia F, Davi S, Horne A, Demirkaya E, Bovis F, Li C, et al. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol. 2014;66(11):3160–9.CrossRef Minoia F, Davi S, Horne A, Demirkaya E, Bovis F, Li C, et al. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol. 2014;66(11):3160–9.CrossRef
23.
go back to reference Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, et al. Ann Rheum Dis. 2016 Mar;75(3):481–9.CrossRef Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, et al. Ann Rheum Dis. 2016 Mar;75(3):481–9.CrossRef
24.
go back to reference Sharpe LR, Ancliff P, Amrolia P, Gilmour KC, Vellodi A. Type II Gaucher disease manifesting as haemophagocytic lymphohistiocytosis. J Inherit Metab Dis. 2009;32(Suppl 1):S107–10.CrossRef Sharpe LR, Ancliff P, Amrolia P, Gilmour KC, Vellodi A. Type II Gaucher disease manifesting as haemophagocytic lymphohistiocytosis. J Inherit Metab Dis. 2009;32(Suppl 1):S107–10.CrossRef
25.
go back to reference Gokce M, Unal O, Hismi B, Gumruk F, Coskun T, Balta G, et al. Secondary hemophagocytosis in 3 patients with organic acidemia involving propionate metabolism. Pediatr Hematol Oncol. 2012;29(1):92–8.CrossRef Gokce M, Unal O, Hismi B, Gumruk F, Coskun T, Balta G, et al. Secondary hemophagocytosis in 3 patients with organic acidemia involving propionate metabolism. Pediatr Hematol Oncol. 2012;29(1):92–8.CrossRef
26.
go back to reference Taurisano R, Maiorana A, De Benedetti F, Dionisi-Vici C, Boldrini R, Deodato F. Wolman disease associated with hemophagocytic lymphohistiocytosis: attempts for an explanation. Eur J Pediatr. 2014;173(10):1391–4.CrossRef Taurisano R, Maiorana A, De Benedetti F, Dionisi-Vici C, Boldrini R, Deodato F. Wolman disease associated with hemophagocytic lymphohistiocytosis: attempts for an explanation. Eur J Pediatr. 2014;173(10):1391–4.CrossRef
27.
go back to reference Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31.CrossRef Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–31.CrossRef
29.
go back to reference Kovtunovych G, Ghosh MC, Ollivierre W, Weitzel RP, Eckhaus MA, Tisdale JF, et al. Wild-type macrophages reverse disease in heme oxygenase 1-deficient mice. Blood. 2014;124(9):1522–30.CrossRef Kovtunovych G, Ghosh MC, Ollivierre W, Weitzel RP, Eckhaus MA, Tisdale JF, et al. Wild-type macrophages reverse disease in heme oxygenase 1-deficient mice. Blood. 2014;124(9):1522–30.CrossRef
Metadata
Title
Heme oxygenase-1 deficiency presenting with interstitial lung disease and hemophagocytic flares
Authors
Alice S. Chau
Bonnie L. Cole
Jason S. Debley
Kabita Nanda
Aaron B. I. Rosen
Michael J. Bamshad
Deborah A. Nickerson
Troy R. Torgerson
Eric J. Allenspach
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2020
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/s12969-020-00474-1

Other articles of this Issue 1/2020

Pediatric Rheumatology 1/2020 Go to the issue